Should I Buy ZJYL? ZJYL 2026 Analysis

Should You Buy Jin Medical International Ltd (ZJYL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

0.140

1 Day change

-6.76%

52 Week Range

1.020

Analysis Updated At

2026/01/30

Not a good buy right now. ZJYL is in a clear bearish trend (SMA_200 > SMA_20 > SMA_5) and just sold off hard (-7.09% regular session, additional weakness post-market). With no Intellectia buy signals and no supportive institutional/insider momentum, the risk of further downside outweighs the near-term upside for an impatient buyer.

Technical Analysis

Trend is decisively bearish: moving averages are stacked down (SMA_200 > SMA_20 > SMA_5), confirming sustained downside momentum. MACD histogram is negative (-0.00147) but contracting, which suggests bearish momentum may be slowing, not reversing. RSI(6)=32.5 is weak/near-oversold but not a reliable standalone buy trigger. Key levels: pivot 0.143 (now below), resistance at 0.17 then 0.186; support at 0.117 then 0.10. Current price (0.1332) sits between pivot and S1, meaning the stock is still vulnerable to a flush toward 0.117/0.10 if selling continues.

Options Data

Positive Catalysts

could act as a short-term sentiment catalyst. Expansion plan: new 430,000 sq ft production facility in Chuzhou to increase capacity. Product narrative: broad wheelchair lineup (30+ models) aimed at elderly/disabled markets.

Neutral/Negative Catalysts

Price action is strongly negative (sharp regular-session drop and further post-market weakness), indicating poor near-term sentiment/liquidity risk. No hedge fund or insider accumulation trends indicated (both neutral). No Intellectia proprietary buy signals today (AI Stock Picker: none; SwingMax: none), reducing odds of an immediate tradeable rebound for an impatient entry.

Financial Performance

Financial data for the latest quarter was not available (snapshot error: list index out of range), so growth trends and the latest quarter season cannot be assessed from the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, implying no clear Wall Street consensus catalysts or support to counter the current bearish tape. Wall Street pros/cons view cannot be reliably summarized from the supplied dataset.

Analyst Rating

Wall Street analysts forecast ZJYL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZJYL is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold